Genetic testing company 23andMe said it has begun bankruptcy proceedings, seeking to maximize value through a ...

Recent health news highlights significant developments, including 23andMe filing for Chapter 11 bankruptcy, with plans to ...

Me is filing for bankruptcy. The genetics company announced it’s starting a court-supervised sale process to restructure its ...

The company filed for bankruptcy after financial challenges over the past few years and a massive data breach in 2023.

A court-supervised sales process is the best way “to maximize the value of the business,” said Mark Jensen, who became chair of the 23andMe board during the newly announced leadership changes.

Pharmaceutical companies and precision medicine companies could also use the data to develop new drugs. It wouldn’t be the ...

The start of 23andMe Holding Co.'s closely watched bankruptcy proceedings offers customers a troubling reminder of their ...

Genetic testing company 23andMe has filed for bankruptcy after struggling with financial difficulties and strategic missteps.

Board and Leadership Changes to Support Restructuring and Sale Process 23andMe also announced that Anne Wojcicki is resigning from her role as Chief Executive Officer, effective immediately, by mutual ...

DNA testing company 23andMe has filed for bankruptcy protection and announced the immediate resignation of its CEO, Anne ...

SAN FRANCISCO, March 23, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe ... course throughout the sale process. There are no changes to the way the Company stores, manages, or protects ...